The Obesity Tipping Point: SELECT and the 2023 Wave of AOM Trials

Friday, October 27, 2023

8:15 AM – 9:15 AM CDT

Location: Texas D

CE: 1 CME/CE

Deborah Bade Horn, DO, MPH, MFOMA

Associate Professor and Medical Director UT Center for Obesity Medicine and Metabolic Performance. Associate Professor, Department of Surgery
UT McGovern Medical School
Angela Fitch, MD,FACP, FOMA

Co-Founder and Chief Medical Officer -Knownwell
Known Well
Ethan Lazarus, MD, FOMA, AMA Delegate

President
Clinical Nutrition Center
Craig Primack, MD, FACP, FAAP, FOMA

Co-Founder
Scottsdale Weight Loss Center

Here we are! At the Obesity the Tipping Point: the critical point in a process or system beyond which a significant and often unstoppable effect or change takes place. Let's look together at the trials and the new molecules that are changing the landscape of Obesity treatment. Agonists, Bi-agonists, Tri-agonists, Monoclonal Antibodies and more. Together, we will break it down to what's meaningful for Monday morning and how to get your clinic and your patients prepared for the future of anti-obesity medications.

Following the lecture given by Dr. Horn, there will be a Presidential Panel with current President Angela Fitch, Past-President Ethan Lazarus, Former President Craig Primack moderated by former President Deborah Horn.

Learning Objectives:

Describe the SELECT trial design and primary outcome.
Understand the SELECT baseline characteristics and top line data.
Identify significant AOMs in the pipeline while evaluating the potential changes in societal attitudes towards obesity treatment.